Skip to main content
Hybrigenics SA logo

Hybrigenics SA — Investor Relations & Filings

Ticker · ALHYG ISIN · FR0004153930 LEI · 9695003KQD0XMJYDX764 PA Professional, scientific and technical activities
Open in API
Filings indexed 145 across all filing types
Latest filing 2019-09-06 AGM Information
Country FR France
Listing PA ALHYG

About Hybrigenics SA

https://www.hybrigenics-services.com/

Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.

Recent filings

Filing Released Lang Actions
Assemblée générale mixte d'Hybrigenics : seconde convocation le 20 septembre 2019
AGM Information Classification · 98% confidence The document explicitly states that the 'Assemblée générale mixte' (Mixed General Meeting) scheduled for September 6, 2019, could not deliberate due to lack of quorum, and a new meeting is called for September 20, 2019. It details the agenda, which includes the 2018 annual accounts and a proposed takeover/merger via asset contribution (apport partiel d'actifs) by DMS Group. The text also provides instructions on how shareholders can vote (internet, correspondence, proxy) and mentions the upcoming publication of a second notice in the BALO (Bulletin des Annonces Légales Officielles). This content is directly related to the formal procedures and materials surrounding a shareholder meeting, specifically concerning voting rights and the agenda items for that meeting. This strongly points towards materials related to the Annual General Meeting (AGM) or the voting process itself. Since the core subject is the rescheduling and logistics of the AGM, AGM-R (AGM Information) is the most appropriate classification, as it covers presentations and materials shared during the AGM, which includes the notice and voting instructions.
2019-09-06 French
Hybrigenics : Convocation à une assemblée générale mixte le 6 septembre 2019
AGM Information Classification · 99% confidence The document is titled 'AVIS DE REUNION VALANT CONVOCATION A L'ASSEMBLEE GENERALE A CARACTERE MIXTE DES ACTIONNAIRES DU 6 SEPTEMBRE 2019' (Notice of Meeting Serving as Notice of Convocation to the Combined General Meeting of Shareholders of September 6, 2019). It explicitly details the agenda for both Ordinary and Extraordinary General Meetings, including resolutions for approving annual accounts (for the year ended Dec 31, 2018), renewing board members, appointing new auditors, and approving a complex partial asset contribution (scission/spin-off). This content is the formal notice and agenda for a shareholder meeting, which aligns perfectly with the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2019-07-29 French
Hybrigenics et DMS Group entrent en négociation exclusive
M&A Activity Classification · 99% confidence The document is a press release dated February 7, 2019, announcing that DMS Group and Hybrigenics have entered into exclusive negotiations for a potential takeover of Hybrigenics via a partial asset contribution involving the DMS Biotech division. This announcement details a proposed corporate transaction, specifically a merger or acquisition activity. Based on the definitions, the 'M&A Activity (Code: TAR)' category is the most appropriate fit for announcements related to merger proposals or takeover bids.
2019-02-07 French
Hybrigenics reçoit une offre de prise de contrôle
M&A Activity Classification · 99% confidence The document is a press release dated January 14, 2019, announcing that Hybrigenics has received a takeover offer ('offre de prise de contrôle') via a partial asset contribution from an unnamed French listed company. It discusses the board's intention to conduct due diligence and notes the withdrawal of a previous unsolicited offer. This content directly relates to a merger or takeover proposal. Based on the definitions, the most appropriate category is 'M&A Activity' (Code: TAR). The document is a direct announcement of the event, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2019-01-14 French
Hybrigenics : Convocation à une nouvelle assemblée générale mixte le 15 janvier 2019
AGM Information Classification · 98% confidence The document explicitly discusses the failure of the 'Assemblée générale mixte' (Mixed General Meeting) held on December 20, 2018, to reach a quorum. It then announces that a new General Meeting will be held on January 15, 2019, to deliberate on the same agenda. This content directly relates to the scheduling and proceedings of a shareholder meeting, specifically announcing a rescheduled meeting due to lack of quorum. This aligns perfectly with the definition of 'AGM Information' (AGM-R), which covers presentations and materials shared during the Annual General Meeting, or related procedural announcements.
2018-12-20 French
Hybrigenics demande à Moonstone Investments de clarifier son offre
Share Issue/Capital Change Classification · 99% confidence The document details an unsolicited proposal received by Hybrigenics regarding an asset contribution in exchange for new shares and convertible bonds. It discusses significant potential dilution (factor 2 to 3.1), financing needs, and the Board's inability to issue a recommendation pending further information. Crucially, it mentions that the Board hopes to discuss the proposal with shareholders at the 'Assemblée Générale Mixte du 20 décembre 2018' (Mixed General Meeting of December 20, 2018). This context strongly suggests a corporate action or transaction proposal that will be put to a shareholder vote. Since the document is an announcement about a major corporate transaction (asset contribution leading to massive dilution) that requires shareholder approval at a General Meeting, it falls under the scope of major corporate actions. While it is not a formal proxy statement (DEF 14A/PSI), the core subject is a transaction proposal that will be voted on. Given the options, this is a significant corporate/financing event. It is not a standard earnings release (ER), interim report (IR), or annual report (10-K). It describes a major financing/capital structure change proposal. Therefore, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it directly addresses the proposed issuance of new shares and convertible bonds as consideration for an asset acquisition.
2018-12-04 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.